CPHI Japan 2024 CPHI Japan 2024

Meet our team of CDMO experts at Booth No.: 5N-20

April 17th to 19th, 2024

Tokyo, Japan

Speak to our Expert

By submittng this form you accept the Privacy Policy and Terms of Use of this website.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
video
Aurigene Pharmaceutical Services Limited is a leading contract research, development and manufacturing organization (CDMO) providing end-to-end solutions. Corporate Video | CDMO - Aurigene Pharmaceutical Services /sites/default/files/2021-04/Corporate%20Video%20_%20CDMO%20_%20Aurigene%20Pharmaceutical%20Services_1_.mp4

The Aurigene expertise

Aurigene Pharmaceutical Services Limited is an integrated partner for global pharma companies. It covers the entire value chain for new therapeutics, from drug discovery, clinical research, and development to manufacturing APIs and formulation at commercial scales. It has development laboratories from discovery to clinical phase III for New Chemical and Biological Entities (NCEs/NBEs) and cGMP manufacturing facilities in the UK, Mexico, USA, and India. The technology platforms include cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins, peptides, and oligonucleotides. Large molecule discovery services include ADC, mAb, mRNA, and CART-T as well as development services in mAb and protein therapeutics.

About CPHI JAPAN 2024

CPHI Japan is the premier annual event for the pharmaceutical industry in Japan. This established exhibition convenes a comprehensive array of professionals across the entire pharmaceutical supply chain. Held at Tokyo Big Sight (East Halls 4, 5 & 6) from April 17th to 19th, 2024, CPHI Japan fosters a unique environment for networking, knowledge exchange, and conducting business with a focus on the Japanese market. It facilitates access to both the domestic and global pharmaceutical supply chains, showcasing a diverse range of exhibitors from all sectors of pharma (ingredients, outsourcing, biopharma, machinery & equipment, DDS & packaging). Pre-event matchmaking services and educational conferences further enrich the experience. CPHI Japan represents a significant opportunity for those interested in entering or expanding their presence within the Japanese pharmaceutical market.

CPHL Japan

Meet our Experts

We are excited to connect with you and explore how we can work together to accelerate your molecule’s journey to the market.

To schedule a meeting with us, simply share your contact information and we will get in touch with you.

Rajeev Hotchandani

Kapil Choudhury

Head - Global Business Development

Hiroyuki Takashima

Hiroyuki Takashimax

Director - Business Development

Abhishek Goel

Abhishek Goel

Director - Business Development

Services we Offer

protac-synthesis-and-screening-service-banner

Discovery Chemistry

Aurigene provides expert solutions for all your synthetic chemistry challenges in drug discovery, with 600+ scientists and advanced facilities.

Drug Discovery

Aurigene helps innovator pharma companies accelerate drug discovery with integrated and standalone chemistry & biology solutions, backed by expert scientists and advanced facilities.

Drug Discovery
Protacs

Protacs Synthesis

Aurigene offers expert PROTAC development & synthesis for targeted protein degradation, with multi-gram scale capabilities and extensive biological, DMPK, and toxicology support.

Oligonucleotide Synthesis

Aurigene offers custom oligonucleotide synthesis with expert support, high-tech equipment, and ability to handle large-scale or complex modifications.

Oligonucleotide
Analytical Chemistry Services

Pharmaceutical Analytical Chemistry Services

Aurigene offers comprehensive pharmaceutical analytical chemistry services, from NCEs and APIs to formulation analysis, using advanced equipment for purification, impurity analysis, and end-to-end support.

Custom Library Synthesis

Aurigene expedites drug discovery through rapid mid-sized library design and synthesis using a diverse in-house chemical collection and efficient gram-scale transformations

Oligonucleotide
Custom Peptide Synthesis Services

Custom Peptide Synthesis Services

Aurigene offers end-to-end custom peptide synthesis, from discovery to manufacturing, catering to diverse peptide structures and aiming to enhance druggability

Early Phase Development and Pilot Facility Services

Aurigene's Early Phase Development and Pilot Facility services provide clients with rapid access to building blocks, intermediates, and drug substances through gram-scale to multi-kilo production, leveraging a team with expertise across all development stages.

Early Phase Development and Pilot Facility Services
Medicinal Discovery Chemistry services

Medicinal Chemistry Services

Aurigene's Medicinal Chemistry Services offer comprehensive solutions for diverse drug discovery needs, leveraging experienced scientists, extensive expertise, and a robust infrastructure.

Why Aurigene Pharmaceutical Services?

images images images images images

CDMO Facility Locations

Hyderabad:

Aurigene Pharmaceutical Services Limited,                                                  
Bollaram Road, Miyapur, Jaya Prakash Narayan Nagar, Miyapur, Telangana 500049

Bangalore:

Aurigene Pharmaceutical Services Limited,                                                  
39-40 Hosur Road KIADB Industrial Area, Joggers Ln, Phase 2, Electronic City, Bengaluru, Karnataka 560100

Visakhapatnam:

APIIC Industrial Estate, Pydibhimavarama (village), Srikakulam district, Andhra Pradesh, India.

UK: API/ RSM Manufacturing Plant

Steanard Ln, Mirfield W14 8HZ, United Kingdom

Mexico:

C.P, Carretera Federal Cuernavaca-Cuautla Km. 4.5 Colonia CIVAC Jiutepec, 62578 Cuernavaca, Mor. Mexico

© 2024 Aurigene Pharmaceutical Services Ltd. | All rights reserved.

logo
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack